First US Bancshares Reports Q1 EPS Growth Amid Rising Charge-Offs and Significant Share Repurchases
FUSB sits 55% above its 52-week low of $10.3.
Summary
First US Bancshares reported increased diluted EPS for Q1 2026, but also saw a rise in nonperforming assets and net charge-offs, alongside a substantial share repurchase program.
Key Events · Earnings and Guidance · FUSB
-
Increased Diluted EPS
Diluted EPS rose to $0.33 in Q1 2026, up from $0.29 in Q1 2025.
-
Deteriorating Asset Quality
Nonperforming assets increased to $1.8 million as of March 31, 2026, from $1.6 million at December 31, 2025. Net charge-offs as a percentage of average loans significantly increased to 0.23% in Q1 2026, compared to 0.13% in Q1 2025.
-
Net Interest Margin Compression
Net interest margin decreased to 3.37% for Q1 2026, down from 3.53% in Q1 2025, due to asset yields declining faster than liability rates.
-
Significant Share Repurchases
The company repurchased 146,500 shares of common stock at a weighted average price of $15.03 per share during Q1 2026, totaling approximately $2.2 million. This is a substantial increase from the 40,000 shares repurchased in Q1 2025.
Analysis · FUSB · Finance
First US Bancshares' Q1 2026 earnings report presents a mixed financial picture. While diluted EPS increased year-over-year, the company experienced a notable rise in nonperforming assets and net charge-offs, indicating a deterioration in credit quality. The net interest margin also compressed, reflecting challenges in the current interest rate environment. A significant share repurchase program was active during the quarter, returning substantial capital to shareholders, but this occurred alongside the weakening asset quality metrics. Investors should carefully weigh the positive earnings growth against the concerning trends in credit health and margin compression.
At the time of this filing, FUSB was trading at $16.00 on NASDAQ in the Finance sector, with a market capitalization of approximately $90.4M. The 52-week trading range was $10.30 to $16.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.